Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Rotavirus Infection Therapeutics Market Growth (Status and Outlook) 2022-2028

  • LP 4916433
  • 88 Pages
  • March 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Rotavirus Infection Therapeutics will have significant change from previous year. According to our (LP Information) latest study, the global Rotavirus Infection Therapeutics market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Rotavirus Infection Therapeutics market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Rotavirus Infection Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Rotavirus Infection Therapeutics market, reaching US$ million by the year 2028. As for the Europe Rotavirus Infection Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Rotavirus Infection Therapeutics players cover GlaxoSmithKline, Bharat Biotech, Curevac, and Ology Bioservices, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Rotavirus Infection Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Oral Drug

Injiectable Drug

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

GlaxoSmithKline

Bharat Biotech

Curevac

Ology Bioservices

BioKangtai

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Rotavirus Infection Therapeutics Market Size 2017-2028

2.1.2 Rotavirus Infection Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Rotavirus Infection Therapeutics Segment by Type

2.2.1 Oral Drug

2.2.2 Injiectable Drug

2.3 Rotavirus Infection Therapeutics Market Size by Type

2.3.1 Rotavirus Infection Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Rotavirus Infection Therapeutics Market Size Market Share by Type (2017-2022)

2.4 Rotavirus Infection Therapeutics Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Retail Pharmacies

2.4.3 Online Pharmacies

2.5 Rotavirus Infection Therapeutics Market Size by Application

2.5.1 Rotavirus Infection Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Rotavirus Infection Therapeutics Market Size Market Share by Application (2017-2022)

3 Rotavirus Infection Therapeutics Market Size by Player

3.1 Rotavirus Infection Therapeutics Market Size Market Share by Players

3.1.1 Global Rotavirus Infection Therapeutics Revenue by Players (2020-2022)

3.1.2 Global Rotavirus Infection Therapeutics Revenue Market Share by Players (2020-2022)

3.2 Global Rotavirus Infection Therapeutics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Rotavirus Infection Therapeutics by Regions

4.1 Rotavirus Infection Therapeutics Market Size by Regions (2017-2022)

4.2 Americas Rotavirus Infection Therapeutics Market Size Growth (2017-2022)

4.3 APAC Rotavirus Infection Therapeutics Market Size Growth (2017-2022)

4.4 Europe Rotavirus Infection Therapeutics Market Size Growth (2017-2022)

4.5 Middle East & Africa Rotavirus Infection Therapeutics Market Size Growth (2017-2022)

5 Americas

5.1 Americas Rotavirus Infection Therapeutics Market Size by Country (2017-2022)

5.2 Americas Rotavirus Infection Therapeutics Market Size by Type (2017-2022)

5.3 Americas Rotavirus Infection Therapeutics Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Rotavirus Infection Therapeutics Market Size by Region (2017-2022)

6.2 APAC Rotavirus Infection Therapeutics Market Size by Type (2017-2022)

6.3 APAC Rotavirus Infection Therapeutics Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Rotavirus Infection Therapeutics by Country (2017-2022)

7.2 Europe Rotavirus Infection Therapeutics Market Size by Type (2017-2022)

7.3 Europe Rotavirus Infection Therapeutics Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Rotavirus Infection Therapeutics by Region (2017-2022)

8.2 Middle East & Africa Rotavirus Infection Therapeutics Market Size by Type (2017-2022)

8.3 Middle East & Africa Rotavirus Infection Therapeutics Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Rotavirus Infection Therapeutics Market Forecast

10.1 Global Rotavirus Infection Therapeutics Forecast by Regions (2023-2028)

10.1.1 Global Rotavirus Infection Therapeutics Forecast by Regions (2023-2028)

10.1.2 Americas Rotavirus Infection Therapeutics Forecast

10.1.3 APAC Rotavirus Infection Therapeutics Forecast

10.1.4 Europe Rotavirus Infection Therapeutics Forecast

10.1.5 Middle East & Africa Rotavirus Infection Therapeutics Forecast

10.2 Americas Rotavirus Infection Therapeutics Forecast by Country (2023-2028)

10.2.1 United States Rotavirus Infection Therapeutics Market Forecast

10.2.2 Canada Rotavirus Infection Therapeutics Market Forecast

10.2.3 Mexico Rotavirus Infection Therapeutics Market Forecast

10.2.4 Brazil Rotavirus Infection Therapeutics Market Forecast

10.3 APAC Rotavirus Infection Therapeutics Forecast by Region (2023-2028)

10.3.1 China Rotavirus Infection Therapeutics Market Forecast

10.3.2 Japan Rotavirus Infection Therapeutics Market Forecast

10.3.3 Korea Rotavirus Infection Therapeutics Market Forecast

10.3.4 Southeast Asia Rotavirus Infection Therapeutics Market Forecast

10.3.5 India Rotavirus Infection Therapeutics Market Forecast

10.3.6 Australia Rotavirus Infection Therapeutics Market Forecast

10.4 Europe Rotavirus Infection Therapeutics Forecast by Country (2023-2028)

10.4.1 Germany Rotavirus Infection Therapeutics Market Forecast

10.4.2 France Rotavirus Infection Therapeutics Market Forecast

10.4.3 UK Rotavirus Infection Therapeutics Market Forecast

10.4.4 Italy Rotavirus Infection Therapeutics Market Forecast

10.4.5 Russia Rotavirus Infection Therapeutics Market Forecast

10.5 Middle East & Africa Rotavirus Infection Therapeutics Forecast by Region (2023-2028)

10.5.1 Egypt Rotavirus Infection Therapeutics Market Forecast

10.5.2 South Africa Rotavirus Infection Therapeutics Market Forecast

10.5.3 Israel Rotavirus Infection Therapeutics Market Forecast

10.5.4 Turkey Rotavirus Infection Therapeutics Market Forecast

10.5.5 GCC Countries Rotavirus Infection Therapeutics Market Forecast

10.6 Global Rotavirus Infection Therapeutics Forecast by Type (2023-2028)

10.7 Global Rotavirus Infection Therapeutics Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Information

11.1.2 GlaxoSmithKline Rotavirus Infection Therapeutics Product Offered

11.1.3 GlaxoSmithKline Rotavirus Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 GlaxoSmithKline Main Business Overview

11.1.5 GlaxoSmithKline Latest Developments

11.2 Bharat Biotech

11.2.1 Bharat Biotech Company Information

11.2.2 Bharat Biotech Rotavirus Infection Therapeutics Product Offered

11.2.3 Bharat Biotech Rotavirus Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Bharat Biotech Main Business Overview

11.2.5 Bharat Biotech Latest Developments

11.3 Curevac

11.3.1 Curevac Company Information

11.3.2 Curevac Rotavirus Infection Therapeutics Product Offered

11.3.3 Curevac Rotavirus Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Curevac Main Business Overview

11.3.5 Curevac Latest Developments

11.4 Ology Bioservices

11.4.1 Ology Bioservices Company Information

11.4.2 Ology Bioservices Rotavirus Infection Therapeutics Product Offered

11.4.3 Ology Bioservices Rotavirus Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Ology Bioservices Main Business Overview

11.4.5 Ology Bioservices Latest Developments

11.5 BioKangtai

11.5.1 BioKangtai Company Information

11.5.2 BioKangtai Rotavirus Infection Therapeutics Product Offered

11.5.3 BioKangtai Rotavirus Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 BioKangtai Main Business Overview

11.5.5 BioKangtai Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Rotavirus Infection Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Oral Drug

Table 3. Major Players of Injiectable Drug

Table 4. Rotavirus Infection Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Rotavirus Infection Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Rotavirus Infection Therapeutics Market Size Market Share by Type (2017-2022)

Table 7. Rotavirus Infection Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Rotavirus Infection Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Rotavirus Infection Therapeutics Market Size Market Share by Application (2017-2022)

Table 10. Global Rotavirus Infection Therapeutics Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Rotavirus Infection Therapeutics Revenue Market Share by Player (2020-2022)

Table 12. Rotavirus Infection Therapeutics Key Players Head office and Products Offered

Table 13. Rotavirus Infection Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Rotavirus Infection Therapeutics Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Rotavirus Infection Therapeutics Market Size Market Share by Regions (2017-2022)

Table 18. Americas Rotavirus Infection Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Rotavirus Infection Therapeutics Market Size Market Share by Country (2017-2022)

Table 20. Americas Rotavirus Infection Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Rotavirus Infection Therapeutics Market Size Market Share by Type (2017-2022)

Table 22. Americas Rotavirus Infection Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Rotavirus Infection Therapeutics Market Size Market Share by Application (2017-2022)

Table 24. APAC Rotavirus Infection Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Rotavirus Infection Therapeutics Market Size Market Share by Region (2017-2022)

Table 26. APAC Rotavirus Infection Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Rotavirus Infection Therapeutics Market Size Market Share by Type (2017-2022)

Table 28. APAC Rotavirus Infection Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Rotavirus Infection Therapeutics Market Size Market Share by Application (2017-2022)

Table 30. Europe Rotavirus Infection Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Rotavirus Infection Therapeutics Market Size Market Share by Country (2017-2022)

Table 32. Europe Rotavirus Infection Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Rotavirus Infection Therapeutics Market Size Market Share by Type (2017-2022)

Table 34. Europe Rotavirus Infection Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Rotavirus Infection Therapeutics Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Rotavirus Infection Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Rotavirus Infection Therapeutics Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Rotavirus Infection Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Rotavirus Infection Therapeutics Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Rotavirus Infection Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Rotavirus Infection Therapeutics Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Rotavirus Infection Therapeutics

Table 43. Key Market Challenges & Risks of Rotavirus Infection Therapeutics

Table 44. Key Industry Trends of Rotavirus Infection Therapeutics

Table 45. Global Rotavirus Infection Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Rotavirus Infection Therapeutics Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Rotavirus Infection Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Rotavirus Infection Therapeutics Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Rotavirus Infection Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Rotavirus Infection Therapeutics Market Size Market Share Forecast by Application (2023-2028)

Table 51. GlaxoSmithKline Details, Company Type, Rotavirus Infection Therapeutics Area Served and Its Competitors

Table 52. GlaxoSmithKline Rotavirus Infection Therapeutics Product Offered

Table 53. GlaxoSmithKline Rotavirus Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. GlaxoSmithKline Main Business

Table 55. GlaxoSmithKline Latest Developments

Table 56. Bharat Biotech Details, Company Type, Rotavirus Infection Therapeutics Area Served and Its Competitors

Table 57. Bharat Biotech Rotavirus Infection Therapeutics Product Offered

Table 58. Bharat Biotech Main Business

Table 59. Bharat Biotech Rotavirus Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Bharat Biotech Latest Developments

Table 61. Curevac Details, Company Type, Rotavirus Infection Therapeutics Area Served and Its Competitors

Table 62. Curevac Rotavirus Infection Therapeutics Product Offered

Table 63. Curevac Main Business

Table 64. Curevac Rotavirus Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Curevac Latest Developments

Table 66. Ology Bioservices Details, Company Type, Rotavirus Infection Therapeutics Area Served and Its Competitors

Table 67. Ology Bioservices Rotavirus Infection Therapeutics Product Offered

Table 68. Ology Bioservices Main Business

Table 69. Ology Bioservices Rotavirus Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Ology Bioservices Latest Developments

Table 71. BioKangtai Details, Company Type, Rotavirus Infection Therapeutics Area Served and Its Competitors

Table 72. BioKangtai Rotavirus Infection Therapeutics Product Offered

Table 73. BioKangtai Main Business

Table 74. BioKangtai Rotavirus Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. BioKangtai Latest Developments

List of Figures

Figure 1. Rotavirus Infection Therapeutics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Rotavirus Infection Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Rotavirus Infection Therapeutics Market Size Market Share by Type in 2021

Figure 7. Rotavirus Infection Therapeutics in Hospital Pharmacies

Figure 8. Global Rotavirus Infection Therapeutics Market: Hospital Pharmacies (2017-2022) & ($ Millions)

Figure 9. Rotavirus Infection Therapeutics in Retail Pharmacies

Figure 10. Global Rotavirus Infection Therapeutics Market: Retail Pharmacies (2017-2022) & ($ Millions)

Figure 11. Rotavirus Infection Therapeutics in Online Pharmacies

Figure 12. Global Rotavirus Infection Therapeutics Market: Online Pharmacies (2017-2022) & ($ Millions)

Figure 13. Global Rotavirus Infection Therapeutics Market Size Market Share by Application in 2021

Figure 14. Global Rotavirus Infection Therapeutics Revenue Market Share by Player in 2021

Figure 15. Global Rotavirus Infection Therapeutics Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Rotavirus Infection Therapeutics Market Size 2017-2022 ($ Millions)

Figure 17. APAC Rotavirus Infection Therapeutics Market Size 2017-2022 ($ Millions)

Figure 18. Europe Rotavirus Infection Therapeutics Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Rotavirus Infection Therapeutics Market Size 2017-2022 ($ Millions)

Figure 20. Americas Rotavirus Infection Therapeutics Value Market Share by Country in 2021

Figure 21. Americas Rotavirus Infection Therapeutics Consumption Market Share by Type in 2021

Figure 22. Americas Rotavirus Infection Therapeutics Market Size Market Share by Application in 2021

Figure 23. United States Rotavirus Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Rotavirus Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Rotavirus Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Rotavirus Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Rotavirus Infection Therapeutics Market Size Market Share by Region in 2021

Figure 28. APAC Rotavirus Infection Therapeutics Market Size Market Share by Application in 2021

Figure 29. China Rotavirus Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Rotavirus Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Rotavirus Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Rotavirus Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Rotavirus Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Rotavirus Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Rotavirus Infection Therapeutics Market Size Market Share by Country in 2021

Figure 36. Europe Rotavirus Infection Therapeutics Market Size Market Share by Type in 2021

Figure 37. Europe Rotavirus Infection Therapeutics Market Size Market Share by Application in 2021

Figure 38. Germany Rotavirus Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Rotavirus Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Rotavirus Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Rotavirus Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Rotavirus Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Rotavirus Infection Therapeutics Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Rotavirus Infection Therapeutics Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Rotavirus Infection Therapeutics Market Size Market Share by Application in 2021

Figure 46. Egypt Rotavirus Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Rotavirus Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Rotavirus Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Rotavirus Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Rotavirus Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Rotavirus Infection Therapeutics Market Size 2023-2028 ($ Millions)

Figure 52. APAC Rotavirus Infection Therapeutics Market Size 2023-2028 ($ Millions)

Figure 53. Europe Rotavirus Infection Therapeutics Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Rotavirus Infection Therapeutics Market Size 2023-2028 ($ Millions)

Figure 55. United States Rotavirus Infection Therapeutics Market Size 2023-2028 ($ Millions)

Figure 56. Canada Rotavirus Infection Therapeutics Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Rotavirus Infection Therapeutics Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Rotavirus Infection Therapeutics Market Size 2023-2028 ($ Millions)

Figure 59. China Rotavirus Infection Therapeutics Market Size 2023-2028 ($ Millions)

Figure 60. Japan Rotavirus Infection Therapeutics Market Size 2023-2028 ($ Millions)

Figure 61. Korea Rotavirus Infection Therapeutics Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Rotavirus Infection Therapeutics Market Size 2023-2028 ($ Millions)

Figure 63. India Rotavirus Infection Therapeutics Market Size 2023-2028 ($ Millions)

Figure 64. Australia Rotavirus Infection Therapeutics Market Size 2023-2028 ($ Millions)

Figure 65. Germany Rotavirus Infection Therapeutics Market Size 2023-2028 ($ Millions)

Figure 66. France Rotavirus Infection Therapeutics Market Size 2023-2028 ($ Millions)

Figure 67. UK Rotavirus Infection Therapeutics Market Size 2023-2028 ($ Millions)

Figure 68. Italy Rotavirus Infection Therapeutics Market Size 2023-2028 ($ Millions)

Figure 69. Russia Rotavirus Infection Therapeutics Market Size 2023-2028 ($ Millions)

Figure 70. Spain Rotavirus Infection Therapeutics Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Rotavirus Infection Therapeutics Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Rotavirus Infection Therapeutics Market Size 2023-2028 ($ Millions)

Figure 73. Israel Rotavirus Infection Therapeutics Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Rotavirus Infection Therapeutics Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Rotavirus Infection Therapeutics Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450